1![A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral–CA1 synapses in hippocampus A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral–CA1 synapses in hippocampus](https://www.pdfsearch.io/img/553480c4915a4cbd515182717e73fa1e.jpg) | Add to Reading ListSource URL: falk.mccormick.northwestern.eduLanguage: English - Date: 2011-03-29 13:34:55
|
---|
2![Neuropharmacology and neurotoxicologyNeuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13 Patric K. Stantona, Pamela E. Potterb, Jennifer Aguilara, Maria Decandiaa and Joseph R. Moskal Neuropharmacology and neurotoxicologyNeuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13 Patric K. Stantona, Pamela E. Potterb, Jennifer Aguilara, Maria Decandiaa and Joseph R. Moskal](https://www.pdfsearch.io/img/b892ba170d32da4b2bc3f963b3b4df06.jpg) | Add to Reading ListSource URL: falk.mccormick.northwestern.eduLanguage: English - Date: 2011-03-29 13:34:57
|
---|
3![NEWS & VIEWS shapes for implementation in imagers. This technology heralds the advent of new classes of imaging devices with wide-angle fields of view, low distortion and compact size. NEWS & VIEWS shapes for implementation in imagers. This technology heralds the advent of new classes of imaging devices with wide-angle fields of view, low distortion and compact size.](https://www.pdfsearch.io/img/e15472d2a4de2d7360f97ff3bd381845.jpg) | Add to Reading ListSource URL: www.ucl.ac.ukLanguage: English - Date: 2008-08-06 17:50:16
|
---|
4![EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West](https://www.pdfsearch.io/img/9a2eea65453f7fe247b890eb0682308c.jpg) | Add to Reading ListSource URL: epa.govLanguage: English - Date: 2013-04-10 16:29:24
|
---|
5![OASAS Buprenorphine Reimbursement in OTP Clinical Guidelines: Opiate agonist (methadone) and partial agonist (buprenorphine) medications can each be dispensed by Opioid Treatment Programs certified by OASAS in accordance OASAS Buprenorphine Reimbursement in OTP Clinical Guidelines: Opiate agonist (methadone) and partial agonist (buprenorphine) medications can each be dispensed by Opioid Treatment Programs certified by OASAS in accordance](https://www.pdfsearch.io/img/ff26e204f94eb9d8bd9068cc99c2c8fd.jpg) | Add to Reading ListSource URL: www.oasas.ny.govLanguage: English - Date: 2014-08-01 14:34:52
|
---|
6![© 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology LETTERS Coupling ligand structure to specific conformational switches in the b2-adrenoceptor © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology LETTERS Coupling ligand structure to specific conformational switches in the b2-adrenoceptor](https://www.pdfsearch.io/img/2ca6e220b98473112c858fc7ed6c14be.jpg) | Add to Reading ListSource URL: med.stanford.eduLanguage: English - Date: 2009-12-04 19:10:52
|
---|
7![THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 27, Issue of July 6, pp[removed]–24436, 2001 © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Accelerated Publication THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 27, Issue of July 6, pp[removed]–24436, 2001 © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Accelerated Publication](https://www.pdfsearch.io/img/73e0b3f38912cfefabeb9061f49f7959.jpg) | Add to Reading ListSource URL: med.stanford.eduLanguage: English - Date: 2009-12-04 19:10:03
|
---|
8![EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West](https://www.pdfsearch.io/img/406e0a0643c001511cb5584460887b1b.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2013-04-10 16:29:24
|
---|
9![Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist) Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist)](https://www.pdfsearch.io/img/d2f7e54aeb80d972cfd293328f81f958.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist) SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist)](https://www.pdfsearch.io/img/7fda0e0bbd6ab29ab00c93e15554dc2a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|